Ketoanalogue for Kidney Disease Market to Grow at a CAGR of 6.5% from 2022 to 2031, reaching US$ 409.6 Million: As per TMR Study Wilmington, Delaware, United States, July 25, 2023 (GLOBE NEWSWIRE) -- The global ketoanalogue for kidney disease market stood at US$ 214.7 million in 2021, and the global market is projected to...